Routine invasive procedures for stable heart disease found to offer no long-term survival advantage over drug therapy

A long-term follow-up of the ISCHEMIA trial found that stable heart disease patients who received early invasive procedures like stents or bypass surgery did not live longer than those treated first with medication and lifestyle changes. Procedures may relieve chest pain and improve quality of life, but they did not improve survival over nearly a decade.